Viewing Study NCT00089856


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-04-06 @ 5:52 PM
Study NCT ID: NCT00089856
Status: TERMINATED
Last Update Posted: 2008-11-05
First Post: 2004-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor: Cell Genesys
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module